• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Chesapeake IRB acquires Goodwyn IRB

Chesapeake IRB acquires Goodwyn IRB

March 27, 2014
CenterWatch Staff

Chesapeake IRB has completed the acquisition of Goodwyn IRB.

Cincinnati-based Goodwyn IRB and Chesapeake IRB, headquartered in Columbia, Md., are providers of federally mandated institutional review board (IRB) services to pharmaceutical, biotech and medical device companies, universities, academic medical centers, hospital systems, governmental entities and others required to use IRB services to assure the protection of rights and the welfare of human participants in research.

“We are excited to acquire Goodwyn IRB," said Felix Gyi, founder and CEO of Chesapeake IRB. "Their operational expertise and commitment to human protection mirrors our own and will be an asset as we continue to build Chesapeake’s market presence as a leading independent IRB.”

Ellen Kelso, founder and CEO of Goodwyn IRB, said “Goodwyn IRB is very pleased to be owned by Chesapeake IRB. We will share best practices across the firms while continuing to offer exceptional institutional review board services and human protection to our clients. They will now be able to utilize Chesapeake’s Center for IRB Intelligence (CIRBI) and have real-time, 24/7 access to all study documents.”

Elyse Summers, president and CEO of the Association for the Accreditation of Human Research Protection Programs, said, “AAHRPP is delighted that two AAHRPP accredited, highly respected, independent IRBs have found the common ground of accreditation as a leverage point to create an enhanced organization.”

 

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing